The so-called “SafeCell” paper from the journal PLoS One is one that a number of advocates of deregulation of the stem cell industry often have mentioned to me: Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials I have read this paper and have some thoughts on it. As with all papers, I try to look for both the strengths and weaknesses in them. One strength is that it appears that the patients were all part of approved, …Read More
Knoepfler lab stem cell blog
